Multi Pharma Private Limited
About Multi Pharma Private Limited
Data last updated:
Multi Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 December 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL2000PTC108952. Its GSTIN is 07AACCM7876R1ZH (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jai Parkash Gupta and Tarun Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T – 2 / 129 Phase – 1 Mangol Puri Industrial Area, New Delhi, Delhi, India – 110083.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.52 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.1 Lakh (net margin -26.9%) and EBITDA of -₹2.99 Lakh (EBITDA margin -25.9%). Revenue has declined at a compounded annual rate (CAGR) of 22% over five years.
Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Multi Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressT – 2 / 129 Phase – 1 Mangol Puri Industrial Area, New Delhi, Delhi, India – 110083
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Multi Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Multi Pharma Private Limited
FY 2025 filings availableMulti Pharma Private Limited reported revenue of ₹11.52 Lakh (up 25503% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -25.9% | ||||
| Net Profit Margin | -26.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Multi Pharma Private Limited, buy the company report.
Board of directors of Multi Pharma Private Limited
Multi Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jai Parkash Gupta Also directs: Atj Techno Fab Private Limited, Marvous Healthcare Private Limited | Director | 20 Dec 2000 | 25 Years 10 Months | Current |
| Tarun Gupta Also directs: Atj Techno Fab Private Limited, Marvous Healthcare Private Limited | Director | 30 Sep 2013 | 13 Years 1 Months | Current |
Peer comparison
Multi Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Holimed Pharmaceutical Private Limited | ₹11.59 Lakh (FY 2024) | -32.0% | New Delhi, Delhi, India | |||
| Vertebra Lifesciences Private Limited | ₹11.59 Lakh (FY 2018) | Rampur, Uttar Pradesh, India | ||||
| Khushia1 Life Care Private Limited | ₹11.58 Lakh (FY 2017) | -2.0% | Alwar, Rajasthan, India | |||
| Snill Meds India Private Limited | ₹11.56 Lakh (FY 2025) | 28.0% | Chennai, Tamil Nadu, India | |||
| R2pexcellent Private Limited | ₹11.53 Lakh (FY 2024) | 690.0% | Mallappally, Kerala, India | |||
| Multi Pharma Private Limitedthis company | ₹11.52 Lakh (FY 2025) | -₹3.1 Lakh | -26.9% | 25503.0% | New Delhi, Delhi, India | |
| Medizen Global Lifescience Private Limited | ₹11.51 Lakh (FY 2025) | Khed, Maharashtra, India | ||||
| Embrace Pharma (OPC) Private Limited | ₹11.48 Lakh (FY 2025) | -55.0% | Salem, Tamil Nadu, India | |||
| Intracare Lifescience Private Limited | ₹11.46 Lakh (FY 2025) | Surat, Gujarat, India | ||||
| Orthonovus Healthcare India Private Limited | ₹11.42 Lakh (FY 2016) | Pune, Maharashtra, India | ||||
| Baby Rural Health Centre Private Limited | ₹11.38 Lakh (FY 2024) | 54.0% | Pattukkottai, Tamil Nadu, India |
To see the full peer comparison of Multi Pharma Private Limited, buy the company report.
Auditor
Multi Pharma Private Limited is audited by RAKESH KUMAR SINGHAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAKESH KUMAR SINGHAL & CO | FY 2019 | 023863N |
Shareholding
The shareholding of Multi Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Multi Pharma Private Limited, buy the company report.
Legal cases
Multi Pharma Private Limited has 4 court cases on record: 3 filed by Multi Pharma, 1 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 2 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal case | Filed by the company against an individual | Pending |
| District court, Muzaffarnagar, Uttar Pradesh | Court case (Cri. Case) | Filed against the company by State of U.P. | Pending |
| District court, North West, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Multi Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Multi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Multi Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCM7876R1ZH | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Multi Pharma Private Limited, buy the company report.
Recent activity
Multi Pharma Private Limited has 5 board changes on record since 2000: 2 appointments and 3 cessations. The latest: Neeraj Gupta ceased to be Director on 01 Nov 2015.
Frequently asked questions
Multi Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 December 2000 (26+ years old) and is registered under CIN U74899DL2000PTC108952.
Multi Pharma has 2 current directors:
- Jai Parkash Gupta - Director
- Tarun Gupta - Director
The latest financial statements of Multi Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Multi Pharma is 07AACCM7876R1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Multi Pharma is U74899DL2000PTC108952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Multi Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 2 are pending.
Multi Pharma was incorporated on 20 December 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Multi Pharma by revenue are Holimed Pharmaceutical Private Limited, Vertebra Lifesciences Private Limited, Khushia1 Life Care Private Limited, Snill Meds India Private Limited, R2pexcellent Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Neeraj Gupta ceased to be Director on 01 Nov 2015. Neeraj Gupta ceased to be Director on 01 Nov 2015. Tarun Gupta ceased to be Additional Director on 30 Sep 2014. Multi Pharma has 5 board changes on record in total.
The registered office of Multi Pharma is at T – 2 129 Phase – 1 Mangol Puri Industrial Area, New Delhi, Delhi, India – 110083.
Multi Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
